06:02 PM EDT, 07/16/2025 (MT Newswires) -- Rachid Izzar, Head of Global Product Strategy, on July 08, 2025, sold 2,223 shares in Biogen (BIIB) for $300,105. Following the Form 4 filing with the SEC, Izzar has control over a total of 6,330 common shares of the company, with 6,330 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875045/000112760225019295/xslF345X05/form4.xml